M 447 (Benazepril 40 mg)

Pill imprint M 447 has been identified as Benazepril hydrochloride 40 mg.

Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 40 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 447

Benazepril hydrochloride 40 mg M 447  Front
Benazepril hydrochloride 40 mg M 447  Back
Benazepril hydrochloride 40 mg M 447
Benazepril hydrochloride
Imprint:
M 447
Strength:
40 mg
Color:
White
Size:
15.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0447
Inactive Ingredients:
lactose anhydrous
silicon dioxide
crospovidone
hypromelloses
polydextrose
polyethylene glycol
corn starch
stearic acid
magnesium silicate
titanium dioxide
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)